{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:55Z","timestamp":1793237695647,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.06.025","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:46:19Z","timestamp":1782161179000},"page":"3745-3747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A structural upgrade for influenza vaccines"],"prefix":"10.1016","volume":"34","author":[{"given":"Mark J.G.","family":"Bakkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8768-0982","authenticated-orcid":false,"given":"Johannes P.M.","family":"Langedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.06.025_bib1","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.ymthe.2026.03.021","article-title":"Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines","volume":"34","author":"Mishra","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.025_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.06.025_bib3","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1038\/s41564-024-01860-1","article-title":"A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses","volume":"9","author":"Bakkers","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2026.06.025_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115379119","article-title":"Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions","volume":"119","author":"Milder","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.025_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aea8770","article-title":"Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice","volume":"18","author":"Dosey","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.06.025_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.06.025_bib7","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1038\/s41467-024-50659-5","article-title":"Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer","volume":"15","author":"Bakkers","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.025_bib8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41467-019-09807-5","article-title":"Transient opening of trimeric prefusion RSV F proteins","volume":"10","author":"Gilman","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.025_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.025_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus","volume":"176","author":"Marcandalli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.06.025_bib11","doi-asserted-by":"crossref","first-page":"12265","DOI":"10.1073\/pnas.1811980115","article-title":"Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4","volume":"115","author":"Stewart-Jones","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.025_bib12","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1038\/s41467-024-48059-w","article-title":"Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein","volume":"15","author":"Langedijk","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:27:11Z","timestamp":1793237231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626005022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626005022"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A structural upgrade for influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}